OIRM established the Clinical Trials Initiative in 2015, based on the expertise of the OIRM researchers/clinicians who are leading or have led clinical trials in Ontario. The Initiative hosts workshops (see bottom) focused on problem solving in the areas of regulatory approval, cell manufacturing, access to cells, patient recruitment and registries, reimbursement strategies, and commercialization.
TRIALS IN ONTARIO 2017
Note: If you are a patient or caregiver seeking information about clinical trials, we recommend you review our FAQs and the featured resources and consult with your physician or specialist.
Trials launching soon:
|Duncan Stewart - OHRI||SAPPHIRE Trial for Pulmonary Arterial Hypertension||Pulmonary Arterial Hypertension||II|
|Lauralyn McIntyre - OHRI||Cellular immunotherapy for septic shock (CISS): A Phase II Multicenter Clinical Trial||Septic Shock||II|
|Don Mabbot - SickKids||Metformin for brain repair in children with Cerebral Palsy||Cerebral Palsy||II|
|Terry Yau - UHN||IMPACT-CABG Trial: IMPlantation of Autologous CD133+ sTem Cells in Patients Undergoing Coronary Artery Bypass Grafting||Heart failure||II|
This trial listing is also available in the graphic format for download and sharing. Click the icon below.
The Clinical Trials Initiative Workshop series has been developed to focus on the translation of research studies from the lab into the clinic. Workshops are held 2-3 times per year, each focusing on a different aspect of this process. Participation is open to OIRM scientists, clinicians, and trainees.
Stay tuned for information on upcoming workshops and events.
April 11th, 2017: Featuring guest speakers Patrick Beford (CCRM), Emily Titus (CCRM) and David Courtman (OHRI), this workshop looked at teh practical issues of regulation and manufacturing for cell-based clinical trials.
November 23 2016: This workshop covered various aspects of clinical trial design and implementation of Phase I/II cell therapy clinical trials. We have three excellent speakers: Dean Ferguson and Monica Taljaard; from OHRI and Pamela Degendorfer of Ozmosis Research Inc.
May 10, 2016: OIRM hosted Patrick Bedford, Senior Policy Analyst, Office of Policy and International Collaboration, Biologics and Genetic Therapies Directorate from Health Canada. Parick provided insight on many topics surrounding clinical trials in Canada. Parick spoke on "Navigating federal regulatory pathways for cell therapy products". To access Patrick's presentation please click here.
February 22, 2016: OIRM hosted a Clinical Trials Reimbursement Workshop surrounding the true cost of clinical trials and the resources available to support these trials. Research and industry partners described the framework of reimbursement policies and engaging with public and private investors. We also hosted a short presentation from each of the OIRM funded Disease Teams presenting their work in the clinical trial space.
September 24, 2015: OIRM's hosted its first Clinical Trials Initiative Workshop, this workshop discussed how to translate science in the lab to clinical trials. Topics including:
- What's needed to get a successful trial started
- Cell manufacturing considerations for clinical translation
- Cell therapy reimbursement modeling
- Conducting cell therapy clinical trials for myocardial repair
- Considerations for clinical trial design
- Working with the MaRS Excite program